The funds will also be used to begin a Phase 3ABSSSI trial in Australia, advance other clinical programs, support an IND submission to the FDA, and provide working capital.
The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the ...
It states the sale of hemp products intended for human consumption or ingestion that are not FDA-approved is illegal, citing a issued by the Mississippi Attorney General’s Office... The FDA has approved ...